plerixafor
(pleh-RIK-suh-for)
A drug used
with granulocyte colony-stimulating factor before an
autologous stem cell transplant in patients with
non-Hodgkin lymphoma or multiple myeloma. It is also being
studied in the treatment of other types of cancer.
Plerixafor helps move stem cells
from the bone marrow to the blood so they can be collected,
stored, and then given back to the patient.
Plerixafor is a type of
hematopoietic stem cell mobilizer. Also called AMD 3100 and Mozobil.